Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 18

1.

The expanding world of stem cell modeling of Huntington's disease: creating tools with a promising future.

Ward JM, La Spada AR.

Genome Med. 2012 Aug 31;4(8):68. doi: 10.1186/gm369. eCollection 2012.

PMID:
22943447
[PubMed]
Free PMC Article
2.

The role of induced pluripotent stem cells in regenerative medicine: neurodegenerative diseases.

Peng J, Zeng X.

Stem Cell Res Ther. 2011 Jul 28;2(4):32. doi: 10.1186/scrt73. Review.

PMID:
21861938
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Intervention of Proliferation and Differentiation of Endogenous Neural Stem Cells in the Neurodegenerative Process of Huntington's Disease Phenotype.

Mazurová Y, Gunčová I, Látr I, Rudolf E.

CNS Neurol Disord Drug Targets. 2011 Jun;10(4):486-99. Review.

PMID:
21495959
[PubMed - indexed for MEDLINE]
4.

Human induced pluripotent stem cells and neurodegenerative disease: prospects for novel therapies.

Jung YW, Hysolli E, Kim KY, Tanaka Y, Park IH.

Curr Opin Neurol. 2012 Apr;25(2):125-30. doi: 10.1097/WCO.0b013e3283518226. Review.

PMID:
22357218
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Pluripotent stem cells and gene therapy.

Simara P, Motl JA, Kaufman DS.

Transl Res. 2013 Apr;161(4):284-92. doi: 10.1016/j.trsl.2013.01.001. Epub 2013 Jan 23. Review.

PMID:
23353080
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Organotypic cultures as tools for optimizing central nervous system cell therapies.

Daviaud N, Garbayo E, Schiller PC, Perez-Pinzon M, Montero-Menei CN.

Exp Neurol. 2013 Oct;248:429-40. doi: 10.1016/j.expneurol.2013.07.012. Epub 2013 Jul 27. Review.

PMID:
23899655
[PubMed - indexed for MEDLINE]
7.

Potential therapeutic applications of differentiated induced pluripotent stem cells (iPSCs) in the treatment of neurodegenerative diseases.

Gao A, Peng Y, Deng Y, Qing H.

Neuroscience. 2013 Jan 3;228:47-59. doi: 10.1016/j.neuroscience.2012.09.076. Epub 2012 Oct 13. Review.

PMID:
23069758
[PubMed - indexed for MEDLINE]
8.

Neurogenesis in Huntington's disease: can studying adult neurogenesis lead to the development of new therapeutic strategies?

Gil-Mohapel J, Simpson JM, Ghilan M, Christie BR.

Brain Res. 2011 Aug 11;1406:84-105. doi: 10.1016/j.brainres.2011.06.040. Epub 2011 Jun 23. Review.

PMID:
21742312
[PubMed - indexed for MEDLINE]
9.

Animal models of Huntington's disease: implications in uncovering pathogenic mechanisms and developing therapies.

Wang LH, Qin ZH.

Acta Pharmacol Sin. 2006 Oct;27(10):1287-302. Review.

PMID:
17007735
[PubMed - indexed for MEDLINE]
Free Article
10.

Genetic manipulations of mutant huntingtin in mice: new insights into Huntington's disease pathogenesis.

Lee CY, Cantle JP, Yang XW.

FEBS J. 2013 Sep;280(18):4382-94. doi: 10.1111/febs.12418. Epub 2013 Jul 31. Review.

PMID:
23829302
[PubMed - indexed for MEDLINE]
11.

Viral-mediated overexpression of mutant huntingtin to model HD in various species.

Ruiz M, Déglon N.

Neurobiol Dis. 2012 Nov;48(2):202-11. doi: 10.1016/j.nbd.2011.08.023. Epub 2011 Aug 25. Review.

PMID:
21889981
[PubMed - indexed for MEDLINE]
12.

Using non-coding small RNAs to develop therapies for Huntington's disease.

Zhang Y, Friedlander RM.

Gene Ther. 2011 Dec;18(12):1139-49. doi: 10.1038/gt.2011.170. Review.

PMID:
22158031
[PubMed - indexed for MEDLINE]
13.

Huntington's disease like-2: review and update.

Margolis RL, Rudnicki DD, Holmes SE.

Acta Neurol Taiwan. 2005 Mar;14(1):1-8. Review.

PMID:
15835282
[PubMed - indexed for MEDLINE]
Free Article
14.

Huntington's disease.

MacDonald ME, Gines S, Gusella JF, Wheeler VC.

Neuromolecular Med. 2003;4(1-2):7-20. Review.

PMID:
14528049
[PubMed - indexed for MEDLINE]
15.

Novel insights into disease modeling using induced pluripotent stem cells.

Egashira T, Yuasa S, Fukuda K.

Biol Pharm Bull. 2013;36(2):182-8. Review.

PMID:
23370349
[PubMed - indexed for MEDLINE]
Free Article
16.

The endocannabinoid system and Huntington's disease.

Lastres-Becker I, De Miguel R, Fernández-Ruiz JJ.

Curr Drug Targets CNS Neurol Disord. 2003 Oct;2(5):335-47. Review.

PMID:
14529364
[PubMed - indexed for MEDLINE]
17.

Thinking outside the liver: induced pluripotent stem cells for hepatic applications.

Subba Rao M, Sasikala M, Nageshwar Reddy D.

World J Gastroenterol. 2013 Jun 14;19(22):3385-96. doi: 10.3748/wjg.v19.i22.3385. Review.

PMID:
23801830
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Systematic review of induced pluripotent stem cell technology as a potential clinical therapy for spinal cord injury.

Kramer AS, Harvey AR, Plant GW, Hodgetts SI.

Cell Transplant. 2013;22(4):571-617. doi: 10.3727/096368912X655208. Epub 2012 Aug 27. Review.

PMID:
22944020
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk